# Pilot Study to evaluateThrombomodulin to Rule Out Giant Cell Arteritis (GCA) in Polymyalgia Rheumatica (PMR) Patients. (THROPIQ)

> **NCT06609668** · — · RECRUITING · sponsor: **Centre Hospitalier Universitaire Dijon** · enrollment: 78 (estimated)

## Conditions studied

- Giant Cell Arteritis (GCA)
- Polymyalgia Rheumatica (PMR)

## Interventions

- **BIOLOGICAL:** Additional blood samples

## Key facts

- **NCT ID:** NCT06609668
- **Lead sponsor:** Centre Hospitalier Universitaire Dijon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-10
- **Primary completion:** 2027-10
- **Final completion:** 2027-10
- **Target enrollment:** 78 (ESTIMATED)
- **Last updated:** 2025-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06609668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06609668, "Pilot Study to evaluateThrombomodulin to Rule Out Giant Cell Arteritis (GCA) in Polymyalgia Rheumatica (PMR) Patients. (THROPIQ)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06609668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*